Xtalks Featured Member: Parminder Singh Bhasin, Senior Director, Head of Analytical Research and Project Management, Intech Biopharm. Ltd

Key Takeaways

• 26+ years leading formulation R&D and ANDA operations worldwide
• Heads analytical research and project management for pMDI, nasal spray, DPI
• Drives global regulatory submissions across US, EU, Canada, APAC markets
• Leads GMP audits, method validation, and technology transfer at Taiwan site
• Focuses on novel dosage forms to improve efficacy and market differentiation

Pulse Analysis

Parminder Singh Bhasin’s career reflects the evolution of pharmaceutical development from bench‑scale formulation to multinational regulatory strategy. Over a quarter‑century, he has built expertise in pre‑formulation studies, patent analysis, and scale‑up processes that meet the stringent requirements of the FDA, EMA, Health Canada, and APAC agencies. This depth of knowledge enables Intech Biopharm to navigate the complex ANDA and 505(b)(2) pathways, positioning the company to launch cost‑effective generics and innovative dosage forms faster than many peers.

In his current role, Bhasin orchestrates cross‑functional teams at the Taiwan site, overseeing analytical method development, validation, and cGMP testing for inhalation products such as pMDIs, nasal sprays, and dry‑powder inhalers. By integrating project management with rigorous quality systems, he ensures seamless technology transfer from R&D to commercial manufacturing while maintaining compliance with ICH guidelines. His hands‑on leadership during GMP audits and CAPA implementation reduces regulatory risk, accelerates product approvals, and supports strategic B2B collaborations with contract laboratories worldwide.

The broader industry benefits from leaders like Bhasin who blend scientific innovation with regulatory acumen. As the market shifts toward patient‑centric delivery systems—extended‑release tablets, soft‑gel capsules, and novel inhalation devices—his focus on therapeutic efficacy and market differentiation drives competitive advantage. Highlighting his achievements through Xtalks not only showcases individual expertise but also fosters networking and knowledge sharing that can inspire the next wave of life‑science breakthroughs.